Lathrop Urgent Care, a Professional Medical Corporation
Lathrop Urgent Care, a Professional Medical Corporation was paid $264K by Medicaid between Jan 2018 and Dec 2024, across 29 billing codes. Its largest line is 96372, Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular — 29% of everything it billed.
LATHROP, CA 95330
Next to other Urgent Care Clinic/Center providers in California
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 3,623 | $65K | |
| 2019 | 2,919 | $25K | |
| 2020 | 2,177 | $18K | |
| 2021 | 2,039 | $16K | |
| 2022 | 1,162 | $21K | |
| 2023 | 1,935 | $31K | |
| 2024incomplete | 3,258 | $87K |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 29% | 4,189 | 1,867 | $78K |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 26% | 2,434 | 2,036 | $67K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 24% | 7,029 | 5,812 | $63K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 4.1% | 551 | 510 | $11K |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 3.2% | 757 | 699 | $8K |
| 99205 | Prolong outpt/office vis | 3.0% | 158 | 157 | $8K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 1.5% | 187 | 175 | $4K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | 1.4% | 191 | 184 | $4K |
| 99402 | 1.1% | 91 | 84 | $3K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 32 | 30 | $2K |
| 99386 | <1% | 67 | 67 | $2K | |
| 94060 | <1% | 39 | 37 | $2K |
17 more codes
| 99203 | Doctor's office visit, new patient (routine) | <1% | 172 | $2K |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 324 | $2K |
| 90791 | Psychiatric diagnostic evaluation | <1% | 15 | $2K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 153 | $1K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 16 | $947.19 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 185 | $926.87 |
| 82948 | <1% | 314 | $847.09 | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 16 | $529.09 |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 12 | $500.00 |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 69 | $482.31 |
| 90674 | <1% | 14 | $341.74 | |
| J1071 | Injection, testosterone cypionate, 1 mg | <1% | 33 | $156.31 |
| 80305 | <1% | 13 | $121.96 | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 12 | $119.35 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 12 | $116.68 |
| 81000 | <1% | 13 | $33.54 | |
| 99385 | 0% | 15 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
| Provider | Location | Paid |
|---|---|---|
| Norcal Urgent Care, INC | Manteca, CA | $264K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.